Dengue type 4 live-attenuated vaccine viruses passaged in vero cells affect genetic stability and dengue-induced hemorrhaging in mice.
Most live-attenuated tetravalent dengue virus vaccines in current clinical trials are produced from Vero cells. In a previous study we demonstrated that an infectious cDNA clone-derived dengue type 4 (DEN-4) virus retains higher genetic stability in MRC-5 cells than in Vero cells. For this study we...
Main Authors: | Hsiang-Chi Lee, Yu-Ting Yen, Wen-Yu Chen, Betty A Wu-Hsieh, Suh-Chin Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3203870?pdf=render |
Similar Items
-
Genetic Stability, Virulence, Immunogenicity and Mouse Hemorrhaging Studies of Dengue Virus Serotype Four Infectious cDNA Clone-derived Viruses: Implications for Live-attenuated Dengue Vaccine Development
by: Lee, Hsiang-Chi, et al.
Published: (2012) -
High genetic stability of dengue virus propagated in MRC-5 cells as compared to the virus propagated in vero cells.
by: Chia-Chyi Liu, et al.
Published: (2008-01-01) -
Current Development and Challenges of Tetravalent Live-Attenuated Dengue Vaccines
by: Hou, Jue, et al.
Published: (2022) -
Dengue and Zika virus infections are enhanced by live attenuated dengue vaccine but not by recombinant DSV4 vaccine candidate in mouse models
by: Rahul Shukla, et al.
Published: (2020-10-01) -
Challenges to the Design of Clinical Trials for Live-Attenuated Tetravalent Dengue Vaccines.
by: Philip K Russell, et al.
Published: (2016-08-01)